Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Liver Cancer Pill Extends Lives

Nexavar Hailed as Breakthrough in Treatment of Advanced Liver Cancer
WebMD Health News
Reviewed by Louise Chang, MD

June 4, 2007 (Chicago) -- After more than 30 years of research and hundreds of studies, a pill has been shown to extend the lives of people with liver cancer, the third leading cause of cancer death worldwide.

In a study of more than 600 people with advanced liver cancer, those given the drug Nexavar lived nearly three months longer than those given a placebo.

Though three months may not sound like much, doctors say the drug represents a breakthrough that will become the standard of care for people with advanced liver cancer.

Researcher Josep M. Llovet, MD, a liver cancer specialist at both Mount Sinai School of Medicine in New York, and the University of Barcelona in Spain, says that doctors have nothing to offer people whose liver cancers are diagnosed at an advanced stage. In the U.S. and Europe, 40% of liver cancers are diagnosed at a late stage; elsewhere in the world, the figure stands at 70%.

“Now for the first time we have a drug that works in this population,” he tells WebMD.

Study Halted Prematurely

Llovet notes that over the past few decades, tests of dozens of other new drugs have failed. In contrast, the results of the study were so striking that the study was halted prematurely so that all participants could be offered Nexavar.

“This is the first time a treatment has ever been shown to offer this kind of survival advantage to these patients,” says A. William Blackstock, MD, a cancer doctor at Wake Forest University School of Medicine in Winston-Salem, N.C.

He says that typically, people diagnosed with advanced liver cancer have only months to live.

Since Nexavar is already approved for use in the treatment for kidney cancer, doctors are likely to prescribe it “off label” to people with liver cancer while awaiting the FDA to formally approve it for that use, he says.

Blackstock moderated a news briefing at which the findings were released at the annual meeting of the American Society of Clinical Oncology.

Nexavar Well Tolerated

In the study, people with advanced liver cancer were randomly assigned to receive either Nexavar or placebo twice a day.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas